Still Standing

Description

STILL STANDING® FOOT SPRAY is a topical formulation designed for application to the feet. The product is packaged in a 0.5 fl oz (15 mL) container, providing a convenient volume for individual use. The formulation is intended to deliver targeted relief and support for foot care.

Uses and Indications

This drug is indicated for the temporary relief of minor pain associated with muscles and joints. Specifically, it is effective for conditions such as arthritis, simple backache, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to instruct patients to shake the product well before use.

For adults and children aged 12 years and older, the recommended dosage is to spray the product on the affected area up to three times daily.

For children under 12 years of age, it is essential to consult a doctor prior to use to determine the appropriate course of action.

Contraindications

Application is contraindicated on wounds or damaged, broken, or irritated skin due to the potential for exacerbating the condition. Contact with eyes or mucous membranes should be avoided to prevent irritation or injury.

Tight bandaging is contraindicated as it may restrict circulation. The use of heating pads in conjunction with this product is not recommended, as it may lead to increased absorption and potential adverse effects. Additionally, puncturing or incinerating the product is contraindicated due to the risk of explosion, as the contents are under pressure. Storage at temperatures exceeding 120°F is also contraindicated to maintain product integrity and safety.

Warnings and Precautions

This product is intended for external use only. It is important to note that the formulation is flammable; therefore, it should not be used while smoking or in proximity to heat or open flames.

Application of this product is contraindicated on wounds or on damaged, broken, or irritated skin. Care should be taken to avoid contact with the eyes and mucous membranes. When using this product, it is essential to keep it out of the eyes, avoid tight bandaging, and refrain from using it in conjunction with a heating pad. The product should be used strictly as directed, and users must not puncture or incinerate the container, as it is under pressure. Additionally, it should not be stored at temperatures exceeding 120°F.

Healthcare professionals should advise patients to discontinue use and consult a physician if the condition worsens, if symptoms persist for more than seven days, if symptoms resolve and then recur within a few days, or if the product is needed for longer than one week. In the event of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients using this product should be aware of several important safety warnings and precautions. This product is intended for external use only and is flammable; therefore, it should not be used while smoking or near heat or flame. It is crucial to avoid applying the product to wounds or damaged, broken, or irritated skin, and to prevent contact with the eyes or mucous membranes.

While using this product, patients should take care to keep it out of the eyes, avoid tight bandaging, and refrain from using it in conjunction with a heating pad. It is essential to use the product only as directed and to avoid puncturing or incinerating the container, as it is under pressure. Additionally, the product should not be stored at temperatures exceeding 120°F.

Patients are advised to stop using the product and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. If the product is needed for longer than a week, medical advice should also be sought.

To ensure safety, this product should be kept out of reach of children and pets. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center should be made.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Still Standing (menthol, unspecified form). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before using this product. For adolescents and adults aged 12 years and older, the recommended dosage is to apply the spray to the affected area no more than 1 to 3 times daily.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

If pregnant or breast-feeding, it is advised to consult a health professional prior to use. No non-teratogenic effects have been specified. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children and pets to prevent accidental ingestion or exposure. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to apply the product to wounds or any damaged, broken, or irritated skin. It is important to emphasize that the product should not come into contact with the eyes or mucous membranes.

Healthcare providers should counsel patients to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Additionally, patients should be advised to stop using the product and seek medical advice if they find they need to use it for longer than a week.

While using the product, patients should be reminded to avoid contact with the eyes and to refrain from bandaging the area tightly. They should also be cautioned against using the product in conjunction with a heating pad. It is crucial to instruct patients to use the product only as directed and to avoid puncturing or incinerating the container, as it is under pressure. Furthermore, patients should be advised not to store the product at temperatures exceeding 120°F.

Storage and Handling

The product is supplied in configurations that may vary, and it is important to handle it with care due to its potential to cause staining. Caution is advised when spraying near fabrics and unprotected surfaces to prevent any unwanted marks.

For optimal storage, the product should be kept in a cool, dry place, away from direct sunlight and extreme temperatures. It is recommended to store the product in its original container to maintain its integrity and effectiveness. Special handling precautions should be taken to avoid contact with sensitive materials and surfaces.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Still Standing, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)